CuraSen Therapeutics
Pre-clinicalCuraSen Therapeutics develops small molecule therapies targeting neuroinflammation for neurodegenerative diseases like Parkinson's and Alzheimer's.
Founded
2018
Focus
Small Molecules
About
CuraSen Therapeutics develops small molecule therapies targeting neuroinflammation for neurodegenerative diseases like Parkinson's and Alzheimer's.
Funding History
2Total raised: $66M
Series B$40MQuan CapitalJan 15, 2022
Series A$26MThe Column GroupJan 15, 2020
Company Info
TypePrivate
Founded2018
LocationSan Carlos, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile